Medicenna Therapeutics Corp. – TSX:MDNA.TO

Add to watchlist

CAD 2.1

+0.37

+21.39%

Market closed

Open in about 6 hours

-19.16%

month

-19.16%

quarter

+321.95%

year

Market Cap	132.90M
Enterprise value	N/A

P/E	-5.64
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	1.65
PEG ratio	0.18
EPS	-0.36

Revenue	N/A
EBITDA	-21.29M
Income	-25.46M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Medicenna Therapeutics Corp. (TSX:MDNA.TO): Profit margin
Jun 2023	0	-2.86M
Sep 2023	0	-3.72M
Dec 2023	0	-4.97M
Mar 2024	0	-13.90M

Medicenna Therapeutics Corp. Financials Estimate

Q Y

Medicenna Therapeutics Corp. (TSX:MDNA.TO): Analyst Estimates
2026	2.75M	-16.95M	-616.44%
2027	14.50M	-8.59M	-59.25%
2028	55.5M	19.49M	35.13%
2029	27.10M	5.57M	20.55%

Analysts Price target
Financials & Ratios estimates

Medicenna Therapeutics Corp. (TSX:MDNA.TO): Debt to assets
Jun 2023	31546000	4.64M	14.73%
Sep 2023	27743000	4.30M	15.52%
Dec 2023	23268000	4.63M	19.94%
Mar 2024	19134000	13.94M	72.87%

Medicenna Therapeutics Corp. (TSX:MDNA.TO): Cash Flow
Jun 2023	-3.46M	0	0
Sep 2023	-3.92M	0	0
Dec 2023	-4.02M	0	0
Mar 2024	-4.84M	0	0

Medicenna Therapeutics Corp. alternative data

Medicenna Therapeutics Corp.
Employees

Medicenna Therapeutics Corp. (TSX:MDNA.TO): Employee count
Aug 2023	16
Sep 2023	16
Oct 2023	16
Nov 2023	16
Dec 2023	16
Jan 2024	16
Feb 2024	16
Mar 2024	16
Apr 2024	16
May 2024	16
Jun 2024	16
Jul 2024	16

Medicenna Therapeutics Corp.
Executives

Insider	Age	Compensation
Dr. Fahar Merchant Ph.D. (1957) Founder, Chairman, Chief Executive Officer & Pres	68	$569,380
Ms. Rosemina Merchant B.Sc., M.E.Sc (1957) Founder, Chief Devel. Officer & Director	68	$465,770
Ms. Elizabeth Williams CPA, CA (1978) Chief Financial Officer & Corporation Sec.	47	$360,880

Frequently Asked Questions (FAQ)

What's the price of Medicenna Therapeutics Corp. stock today?

One share of Medicenna Therapeutics Corp. stock can currently be purchased for approximately $2.1.
When is Medicenna Therapeutics Corp.'s next earnings date?

Unfortunately, Medicenna Therapeutics Corp.'s (MDNA.TO) next earnings date is currently unknown.
Does Medicenna Therapeutics Corp. pay dividends?

No, Medicenna Therapeutics Corp. does not pay dividends.
How much money does Medicenna Therapeutics Corp. make?

Medicenna Therapeutics Corp. has a market capitalization of 132.90M.
What is Medicenna Therapeutics Corp.'s stock symbol?

Medicenna Therapeutics Corp. is traded on the TSX under the ticker symbol "MDNA.TO".
What is Medicenna Therapeutics Corp.'s primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Medicenna Therapeutics Corp.?

Shares of Medicenna Therapeutics Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Medicenna Therapeutics Corp.'s key executives?
Medicenna Therapeutics Corp.'s management team includes the following people:
- Dr. Fahar Merchant Ph.D. Founder, Chairman, Chief Executive Officer & Pres(age: 68, pay: $569,380)
- Ms. Rosemina Merchant B.Sc., M.E.Sc Founder, Chief Devel. Officer & Director(age: 68, pay: $465,770)
- Ms. Elizabeth Williams CPA, CA Chief Financial Officer & Corporation Sec.(age: 47, pay: $360,880)
Is Medicenna Therapeutics Corp. founder-led company?

Yes, Medicenna Therapeutics Corp. is a company led by its founders Dr. Fahar Merchant Ph.D. and Ms. Rosemina Merchant B.Sc., M.E.Sc.
How many employees does Medicenna Therapeutics Corp. have?

As Jul 2024, Medicenna Therapeutics Corp. employs 16 workers.
When Medicenna Therapeutics Corp. went public?

Medicenna Therapeutics Corp. is publicly traded company for more then 8 years since IPO on 8 Mar 2017.
What is Medicenna Therapeutics Corp.'s official website?

The official website for Medicenna Therapeutics Corp. is medicenna.com.
Where are Medicenna Therapeutics Corp.'s headquarters?

Medicenna Therapeutics Corp. is headquartered at 2 Bloor Street West, Toronto, ON.
How can i contact Medicenna Therapeutics Corp.?

Medicenna Therapeutics Corp.'s mailing address is 2 Bloor Street West, Toronto, ON and company can be reached via phone at +41 66485555.

Medicenna Therapeutics Corp.

medicenna.com

Exchange:

TSX

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. Its lead product is MDNA55, an interleukin- 4 (IL-4) EC that has completed Phase IIb clinical trial for the treatment of recurrent glioblastoma, as well as preclinical and clinical development stages for the treatment of other brain and non-brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. The company is headquartered in Toronto, Canada.

+41 66485555

2 Bloor Street West
Toronto, ON M4W 3E2

:
ISIN: CA58490H1073
: